Several synthetic 2'-0-methyl-RNA oligomers and their derivatives have been evaluated for inhibitory effect against HIV-induced cytopathic effect and expression of the virus specifio antigen in cultured MT-4 cells. In this study, oligo(2'-0-methyl)ribonucleoside phosphorothioates showed a potent inhibitory activity with size dependency (25-mer showed it at 1 puM), but by contrast both 2'-0-methylribo-and deoxyoligomers with normal phosphate linkages failed to inhibit. However, it should be noted that the patched oligo(2'-0-methyDribonucleotide (20-mer), in which five linkages at 5'-and three linkages at 3'-ends of normal phosphates were replaced with thiophosphates, has recovered the substantial inhibitory effect. These results show that the size of oligomer and phosphorothloate linkages, probably resistant to exolytic nucleases, are essential for exhibiting antiviral activity.
INTRODUCTION
Anti-sense oligodeoxynucleotides and their several modified analogs are widely used as tools for regulating specific gene expression (1) , for blocking splicing and translation of m-RNA (2-5) and for inhibiting viral replication (6) (7) (8) (9) . Recently the antiviral activities against HIV using oligodeoxynucleotides (10,11) and their phosphorothioate analogs (12, 13) have been independently reported, representing that those abilities to exhibit antiviral activities seem to be strongly concerned with resistance to some kinds of deoxynucleases. But no one has yet examined "ribo-type oligomer" for this activity.
Synthetic oligo(2'-0-methyl)ribonucleotides have been utilized in the form of chimeric oligomers with DNA oligomers for the site-directed cleavage of RNA with RNase H (11, 15) and the unidirectinal deletion of DNA by Bal 31 nuclease (16) .
These were accomplished on the bases of their characteristic properties: less susceptibility to several nucleases (17) , formation of a stable heteroduplex with the complementary RNA (18) and easy preparation on an automated DNA synthesizer (15) . In this report, we describe the syntheses of oligo(2'-0-methyDribonucleotides, their phosphorothioate analogs and also homooligo(2'-O-methyl)ribonucleoside phosphorothioates , and their antiviral effects against HIV in cultured human T cells.
MATERIALS AND METHODS Syntheses of oligomers
The structures and the sequences of oligomers used in this study were designed by referring to the sequence of HIV genome previously reported (19) and shown in figure 1.
For the syntheses of oligo(2'-O-methyl)ribonucleotides and their phosphorothioate derivatives, 3'-0-methylribonucleosidesbounded CPGs (described below) were used as starting materials. 01igo(2'-0-methyl)ribonucleotides and oligodeoxynucleotides having normal phosphodiester linkages were prepared by the published phosphoramidite method (15, (20) (21) (22) and purified by C-18 HPLC (YMC-Pak ODS, 6mm<l> x 300mm, Yamamura Chemical Laboratories, Kyoto, Japan) with a linear gradient of acetonitrile (5% -25% for ^0 min) in 0.1 M triethylammonium acetate buffer (pH7.0). 01igo(2 '-O-methyDribonucleoside phosphorothioates as well as oligodeoxynucleoside phosphorothioate were synthesized by H-phosphonate method (23) (24) (25) (26) as follows. The chain elongation reactions were performed on Applied Biosystems Synthesizer model 38OA. For each coupling reaction, 20 equiv. of nucleoside H-phosphonate and 100 equiv. of pivaloyl chloride in acetonitrile and pyridine (1:1) were used for 3 min, and 3% trichloroacetic acid in dichloromethane for 3 min was used for each detritylation step. After the chain elongation cycles, the resin was treated with 0.2M Ss in a mixture of CS2-pyridlne-triethylamine (12:12:1) at room temperature for at least 1 hr, and then with c-NH 4 0H at 55°C for 6-12 hr. After 80% acetic acid treatment, the deprotected oligomers were purified by C-18 HPLC (YMC-Pak ODS, 6mm<t> x 300mm, Yamamura Chemical Laboratories, Kyoto, Japan) with a linear gradient of acetonitrile (10% -50% for HO min) in 0.1 M triethylammonium acetate (pH 7.0). 31p-NMR spectra of oligo(2'-0-methyl)ribonueleo3ide phosphorothioates were measured by JEOL. GX-400FT-NMR at 161.83 MHz in D2O-IO mM triethylammonium bicarbonate (pH 7.5) using trimethylphosphate as an external standard, and multiplet peaks were observed between 51-55ppm.
A large scale preparation of HS-2b (see figure 1 ) for plaque forming assay was performed by hand in the filter funnel packed with 88umol of 3'-O-methylribonucleoside-loaded CPG (described below) on the same conditions for the chain elongation and detritylation steps as described above, and 9.1umol of pure HS-2b was obtained by a middle pressure liquid chromatography using Lobar LiChroprep RP-18 column (25mm$ x 310mm, Merck, Darmstadt, F. R. Germany) with a linear gradient of acetonitrile (10%-50% for 3.8 hr) in 0.1 M triethylammonium acetate (pH 7.0).
The patched oligomer HSOS-2 (20-mer, see figure 1 ) was synthesized manually as described above from 3.3limol of-3'-0-methylribonucleoside-loaded CPG except that oxidation reactions were performed on the way of chain elongation cycles operating as following order: 1) five cycles of coupling reactions, 2) sulfer treatment, 3) nine cycles of coupling reactions, 1) 0.1 M I2 oxidation for 10 min at room temperature, 5) five cycles of coupling reactions, 6) sulfer treatment. The deprotection and purification were performed by the same method as oligo(2'-0-methyl)ribonucleoside phosphorothioates and 0.28urnol of HSOS-2 was obtained. 3ip-NMR analysis of HSOS-2 indicated that it had seven phosphorus atoms assigned to thiophosphates and twelve phosphorus atoms to phosphates. Considering NMR data and the order of oxidation process because of I2 treatment making reconversion of P-S bonds to P-0, we determined the structure of HSOS-2 in which two phosphates on the average within five from 3'-end of HO-2 were substituted by thiophosphates whose exact positions could not be identified, and on the other hand five phosphates from 5'-end were completely substituted.
As materials for H-phosphonate method, the protected 2'-0-methyl-ribonucleoside-H-phosphonates were prepared according to the published procedure (26) . 3lp_NMR spectra of them were recorded on Varian XL-300 operating at 121.12 MHz using phosphoric acid as an external standard in ds-pyridine. The chemical shifts of them were as follows:
, -0. ^(0 ppm. 5'-0-dimethoxy-or monomethoxytrityl, N-acyl-3'-0-methylnucleosides bounded CPGs (long chain alkylamine controlled pore glass support, purchased from Pierce Chemical, Rockford, IL.) were prepared according to published procedure (27, 28) and used as starting materials for coupling reactions (loading contents, 27-30 umol/g).
Every HPLC purified oligomer was used after lyophilization and every phosphorothioate oligomer was used as a mixture of stereolsomers at phosphorus for biological experiments. Cells
The HTLV-I-carrying cell line, , and the HIVproducing cell line, MOLT-4/HIVHTLV-MB (30) , were used in this study. The cells were maintained in RPMI 1640 medium supplemented with 10 % fetal calf serum, 100 U/ml of penicillin, and 100 ug/ml of streptomycin at 37°C in a CO2 incubator. Virus and virus infection HTLV-DIB, one of the HIV strains, was obtained from the culture supernatant of MOLT-1/HIVHTL.V-IHB cells (30) . The titer of this virus preparation was 106 plaque forming units (PFU)/ml. Infection of MT-4 cells with HTLV-DIB was made at a multiplicity of infection of 0.002 as described previously (31, 32) . Briefly, MT-1 cells were exposed to HIV and incubated for 60 min at 37*C for virus adsorption. After adsorption, infected cells were washed and resuspended in fresh medium to make a concentration of 3 x 105 cells/ml. This infected cell suspension wa3 then cultured in the presence of various concentrations of oligomers in a CO2 incubator. The number of cells were counted by the trypan blue dye exclusion method on day 3 after infection, half medium was changed with fresh medium containing the same concentration of oligomer, and then culture was continued for more 3 Phosphorothioate analog of oligo(2'-0-methyl)ribonucleotide (HS-2b) showed the inhibitory effect similar to that of oligodeoxynucleotide (DS-2) (see figure 2a and 2b) , but HS-2b did not affect the growth of HIV-uninfected MT-4 cells at the concentration of 120 uM (data not shown). On the other hand we could not detect any inhibitory effects of both oligo(2'-0-methyDribonucleotide (HO-2) and oligodeoxynuoleotide (DO-2) even at the highest concentration of 120 pM, tested in this assay (see figure 2c and 2d about HO-2 and data not shown about DO-2). Similar results to the above experiment were observed, when tRNA primer binding site wa3 selected as a different target region, showing that phosphorothioate analog of oligo(2'-0-methyl)ribonucleotide (HS-1) had also antiviral activity (see figure 2a and 2b for HS-1, data not shown for oligo(2'-0-methyl)ribonucleotide (H0-1) and their structures were shown in figure 1) .
In a series of phosphorothioate analogs of oligodeoxynucleotldes having anti-HIV activity, it has been pointed out that oligomers having G+C rich sequences are preferable to show potent activities (12, 34) . On the other hand, we obtained a result which was unaccountable for on G+C content alone. Namely, HS-1 and HS-2b, whose G+C contents were 71 % and 40 %, 
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• HSOS-2 0 HO-2 01igo(2'-0-methyl)ribonucleotide is known to be more stable against several nucleases than deoxy-and ribo-oligonucleotides (17 and unpublished data) and can form a stable hetero duplex with its complementary oligoribonucleotide (18) . In the above results, however, several oligomers of normal phosphodiester (HO-2 and HO-1) have not shown any anti-HIV aotivity in our experimental condition, while pho3phorothioate analogs of them with the same sequences (HS-2b and HS-1) have exhibited strong anti-HIV effect which is also similar level to that of oligodeoxynucleotide (DS-2). The result obtained above using oligo(2'-0-methyl)ribonucleotide series is coincident with that reported in the case of oligodeoxynucleotide series (12) . We consider this is due to the instability of normal phosphodiester linkages in our experimental condition, even in the case of oligo(2'-0-methyl)ribonucleotides. This suggests that a part of characters of "nucleases" might be involved in degradation of both deoxy-and ribo-type-oligomers.
Anti-HIV activity of HSOS-2
In order to know the functional structure of active phosphorothioate oligomers, namely the role of whole phosphorothioate linkages of active materials, a patched derivative (HSOS-2), in which twelve phosphorothioate linkages in the middle of HS-2b were replaced by phosphate linkages, was prepared and served for the same assays. This also exhibited substantial anti-HIV effect which was slightly less than HS-2b but remarkably recovered from HO-2 ( figure 2a, 2b, 2c and 2d ). This fact shows that all their thiophosphate linkages are not necessary for this kind of oligomers to exhibit anti-HIV activity. This result also suggests that the suspected nucleases could break down phosphodiester bonds mainly in the manner of exonucleolytic rather than endonucleolytic cleavage on oligo(2'-0-methyl)ribonucleotides.
Effect of oligomer length on anti-HIV activity
To investigate the influence of oligomer length on the anti-HIV activities, additional phosphorothioate analogs of oligo(2'-0-methyl)ribonucleotides;
HS-2a (25-mer), HS-2c (17-mer) and HS-2d (10-mer), which were complementary to splicing acceptor region (figure 1), were prepared and tested on the same assays with HS-2b (20-mer) . Figure 3a and 3b show a remarkable length dependency of these on the anti-HIV activity. (table 1) .
Under these experimental conditions no difference in cell growth was noted in both cell cultures. Results showed that there was no significant difference in the number of plaques as well as in the production of p24 antigen The result that non-sense homooligo(2'-0-raethyl)-ribonucleoside phosphorothioates exhibited the actual inhibitory effects against HIV as same as anti-sense oligomers mentioned above is similar to that reported in oligodeoxynucleotide series (12) , except for the order of activities depending on nucleotide species, or in terms of nucleic acids bases. In our case of oligo(2'-0-methyl)-ribonucleotide series, MIS-20 (inosine derivative) has potent and MCS-20 (cytidine derivative, data not shown) has poor anti-HIV activities, whereas it is reported that oligo-dC has potent in oligodeoxynucleotide series (12) . However, it is unclear what are reflected by the species of nucleotide bases, for example, resistance to degradation, membrane permeability, or non-specific binding ability to the viral genome. Further investigations are required to know the precise meohanism(s) of action of phosphorothioate analogs of homooligo(2'-0-methyl)ribonucleoside, including those of the complementary oligomers.
In conclusion, synthetic oligo(2'-0-methyl)ribonucleotides have anti-HIV activity in cultured cells in the form of phosphorothioate or in the partially phosphorothioatesubstituted form, so that these have a potential to become a candidate worthy of further exploration for AIDS-treatment.
